Skip to search formSkip to main contentSkip to account menu

EO 5A

Known as: EO-5A, EO5A 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Indolequinones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Simultaneous Quantitative Analysis of EO9 (Apaziquone) and its Conversion Products EO5a and EO9-Cl in Human and Dog Urine by High-Performance Liquid Chromatography Coupled with Electrospray Tandem…
A sensitive and specific LC-MS/MS assay for the quantitative determination of anticancer agent EO9 and its conversion products… 
2008
2008
Enhanced resolution triple-quadrupole mass spectrometry for ultra-sensitive and quantitative analysis of the investigational anticancer agent EO9 (apaziquone) and its metabolite EO5a in human and dog…
A highly sensitive and selective liquid chromatography/tandem mass spectrometric (LC/MS/MS) method was developed to quantify the… 
2007
2007
EO-9 bladder instillations: formulation selection based on stability characteristics and in vitro simulation studies.
2006
2006
Quantitative analysis of EO9 (apaziquone) and its metabolite EO5a in human plasma by high-performance liquid chromatography under basic conditions coupled to electrospray tandem mass spectrometry.
A sensitive and specific LC-MS/MS assay for the quantitative determination of EO9 and its metabolite EO5a is presented. A 200… 
1998
1998
Pharmacological and biochemical determinants of the antitumour activity of the indoloquinone EO9.
1994
1994
Clinical studies with EO9, a new indoloquinone bioreductive alkylating cytotoxic agent. EORTC Early Clinical Trials Group.
EO9 [3-hydroxy-5-aziridinyl-1-methyl-2-(1H-indole-4,7-indione)-prop-be ta- en-alpha-ol] is a new bioreductive alkylating… 
1993
1993
Sensitive isocratic high-performance liquid chromatographic determination of a novel indoloquinone cytotoxic drug (EO9) in human plasma and urine.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)